SUMMARY We observed a young woman who showed growth of a choroidal melanoma over the course of 2 pregnancies, with subsequent enucleation of the eye. This is the first such documented case. In addition 4 other women with uveal malignant melanomas presented during pregnancy. This observed number of pregnancies (5) Endocrine influences on cutaneous malignant melanoma have been explored for many years. "-16 In contrast, the effect of endocrine factors on ocular melanomas has received little attention. A few anecdotal references3 1718 and case reports'922 of uveal melanomas occurring during pregnancy could be found in the literature. However, no one has reported whether or not growth of a uveal melanoma occurs during pregnancy or explored hormonal aspects of ocular melanoma or uveal tissue.
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Studies of cutaneous melanoma on differences in incidence and mortality according to sex yield contradictory results.'' The association between cutaneous melanoma and pregnancy or hormonal status among women is also equivocal. 7'6 Some report a better prognosis in women than in men3 or in pregnant than in nonpregnant women.' However, a few find no significant differences in outcome according to sex,' pregnancy,' [5] [6] [7] On the other hand some epidemiological studies reveal a higher incidence and mortality for cutaneous melanoma in women of reproductive and menopausal age than in men."I 12 Similarly, other reports suggest an unfavourable effect on prognosis when melanomas are exacerbated during pregnancy'3 or when stage II melanomas are related to pregnapcy. 1" Activation of naevi or melanomas with use of birth control pills, '5 during pregnancy,'6 and after oestrogen administration'2 has been observed. Furthermore some animal studies imply changing growth patterns of skin melanoma in animals of differing hormonal status.'3232' Such cli-nical findings arouse the suspicion that some patients with cutaneous melanoma may respond to hormonal stimuli. Since uveal and skin melanocytes both derive from the neural crest, it is reasonable to propose that similar mechanisms may play a role in ocular melanoma.
Steroid hormone receptors have also been studied in an effort to understand honnonal influences on malignancies. The Since the tumour samples were small (tumour average net weight 98 mg, choroid average weight 61 mg), duplicate single saturating dose assays at 2 nM3H oestradiol in the absence and presence of 250-fold molar excess of unlabelled diethylstilbestrol were performed.
Results
Five white women ranging in age from 22 to 35 presented during their fourth to seventh months of pregnancy with uveal malignant melanoma ( Table 1 ). All delivered full-term normal infants. Two of them subsequently died of metastatic malignant melanoma. CASE 1 This 27-year-old white female was first seen on 30 October 1978, with the complaint of pain in the left eye of 2 days' duration followed by oedema and redness of the eyelids and decreased vision. At this time she was 7 months pregnant. There was no significant past ocular history. She had been on birth control pills from about March 1977 to March 1978. Family history revealed that her mother died of stomach cancer.
Her last ocular examination, in April 1973 by an optometrist, revealed normal visual acuity in both eyes. Ocular examination of the right eye was normal. Visual acuity OS was counting fingers at 1 foot (30 cm). Visual field examination revealed a central scotoma, almost complete loss of the superonasal quadrant, with marked constriction superotemporally. She had moderate oedema and erythema of the lids, with minimal conjunctival injection and chemosis. There was an afferent pupillary defect. Ocular motility was normal. Slit-lamp examination of the cornea and anterior chamber was unremarkable. Applanation intraocular pressures were 15 mmHg, 10 mmHg OS. In the fundus of the left eye was a dark lesion measuring about 3 x4 disc diameters located 11/2 disc diameters temporal to the disc involving the macula (Fig. 1A) Pathological examination. On gross examination of the eye a pigmented choroidal tumour was seen surrounding the optic nerve. It extended 10 mm temporally from the disc atid 2 mm nasally. The temporal aspect of the tumour was a circumscribed mass elevated 3 mm, while the remainder of the tumour had a more flat, diffuse configuration with an elevation of 1-2 mm (Fig. 3A) . The retina was totally detached.
Histologically the tumour contained areas of dense connective tissue (Fig. 3B) . Spindle A, spindle B, and epithelioid cells were present, with a diagnosis of mixed cell type. 35 There were nests of naevus-like cells at the edge of the tumour adjacent to the optic nerve. Tumour cells were seen invading the optic nerve anterior to the lamina cribrosa and scleral emissary canals (Fig. 3C ). Bruch's membrane was not ruptured. A moderate amount of chronic nongranulomatous inflammation was present within the tumour. The retina was detached, and areas of associated retinal pigment epithelium had undergone fibrous metaplasia. The cornea, anterior chamber, lens, iris, and ciliary body appeared normal. Electron microscopy of this melanoma revealed bundles of collagen (Fig. 4) (Fig.  5A) . The surrounding retina was detached. There was no gross extrascleral or optic nerve extension.
Histologically the tumour was composed of a mixture of spindle A and spindle B type cells (Fig. 5B) . No epithelioid cells were seen and Bruch's membrane was not ruptured. There were a minimal number of chronic inflammatory cells. A shallow detachment involving the macula was present. Degeneration of photoreceptors and outer nuclear layer of the retina was seen overlying the tumour. There was superficial involvement of sclera by tumour cells. The anterior segment was normal. CASE 3 This 35-year-old woman presented in her fifth month of pregnancy in July 1956 with a history of blurred vision OD for 2 weeks. She had no previous ocular problems. Her best corrected visual acuity was 20/70-2 OD and 20/20 OS. Applanation intraocular pressures were 17 mmHg OU. Fundus examination revealed an elevated mass inferior to the macula 3 to 4 disc diameters in its widest dimension. There was macular oedema and a retinal detachment overlying the mass. The left eye was normal. She was seen at the MEEI and consultants agreed that the lesion was a malignant melanoma. The right eye was enucleated on 21 August 1956.
She was delivered of a normal daughter on 17 November 1956. Since then she and her daughter have remained in good health with no systemic problems.
Pathological examination. A minimally pigmented choroidal tumour 6 mm in largest diameter and 2 mm in height was located in the posterior pole involving the macula. The cell type was classified as spindle B in a fascicular arrangement. Compact spindle cells were present at the base of the tumour. Bruch's membrane was not ruptured. There was minimal invasion of the inner aspect of the sclera. CASE 4 This 22-year-old woman presented in September 1969 when she was 6 months pregnant with a 4-day history of blurred vision OS. She had no significant past ocular history. Her family history was significant for cancer; her sister died from a central nervous system malignancy at age 16 and a paternal uncle was treated for cutaneous malignant melanoma. Her visual acuity was 20/15 OD and 20/400 OS. Applanation intraocular pressures were 16 mmHg OU. A choroidal tumour was seen inferotemporally in the left eye extending from the ora to posterior to the equator with a retinal detachment at the edges ofthe tumour. Examination of the fundus OD was normal. Consultants agreed that this was a malignant melanoma OS. The left eye was enucleated on 22 September 1969.
She was delivered of a full-term baby in December 1969. Three and a half years later she developed a carcinoma in situ of the cervix and underwent a total hysterectomy in May 1973. Slides of the cervical lesion have been reviewed and the diagnosis has been confirmed by the authors. In November 1974, she noticed multiple nodules in her right breast which were biopsied and subsequently verified by the authors as metastatic malignant melanoma of mixed cell type. Chemotherapy and BCG therapy were started in June 1975. A liver scan was suspicious for early metastatic disease. In September 1976 she developed multiple bone metastases, which were treated with radiotherapy. She later developed extensive subcutaneous melanotic nodules. 
was normal. Her left eye had minimal conjunctival injection. She had a superior peripheral iridectomy OS. A pale vascularised mass was present on the anterior surface of the iris inferiorly (Fig. 6) . There was also a subconjunctival mass at the limbus inferiorly. The pupil OS was irregular, and the anterior chamber was normal in depth. Table 2 . Oestrogen receptors were not found, suggesting that oestrogen receptor activity may not be involved in the presentation or growth of ocular melanomas. This assumption is consistent with the finding that cutaneous melanomas show a poor response to endocrine therapy37 and that the putative responses to hormone therapy in cutaneous melanoma have no correlation with the presence of receptor.38 Our receptor test group was small, with only one a melanoma of pregnancy, so a larger number of this relatively rare condition needs to be examined before the statistical significance of the findings can be established.
Questions that remain unanswered include: are uveal melanomas of pregnancy different from tumours in nonpregnant age-matched cases with respect to receptor frequency and concentration? Are there significant receptor differences between males and females, and do values change with age?
The absence of oestrogen receptor, however, does not rule out the possibility that oestrogens may influence tissue by a mechanism not involving a receptor, or that they may exert an indirect effect via the regulation of other hormones or factors that directly affect the melanoma. Other possibilities for hormone control other than oestrogens include a direct effect of melanocyte stimulating hormone,3 androgens,' or other trophic factors.
Another possible mechanism is that pregnancy may be associated with decrease of a systemic inhibitor allowing stimulation of growth. An immunological rather than hormonal mechanism consistent with this theory is the recent evidence that fetal suppressor cells are present which affect maternal adult lymphocytes and alter the mother's immunological reactivity, preventing rejection of the fetal allograft.' Moreover proteins produced by the mother4' or a reduction in levels of maternal helper T cells42 may partly explain survival of the fetus. Changes in cellular and humoral immunity43 occur during pregnancy and are thought to be responsible for the diminution during pregnancy of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis. Pregnancy has also been found to exert a beneficial effect on the Vogt-Koyanagi-Harada syndrome. 45 Similarly, perhaps an increase in immunosuppression-related problems could occur which, for example, would allow development or growth of a pre-existing slow growing melanoma in the eye. Immunodeficiency states are associated with an increased incidence of neoplasia,46 but this has not been explored in the pregnant state.
To evoke an immunological mechanism there should be evidence that melanoma is an antigenic tumour. Virus-induced tumours are almost always antigenic, and there is suggestive evidence that at least some ocular melanomas contain virus.47 Moreover, evidence of immunological effects in melanoma patients has been demonstrated. 48 Our clinical observations pose the following questions: (1) Do pregnancy and other hormonal changes influence the occurrence of uveal melanomas? (2) Does pregnancy affect the course and prognosis of uveal melanomas, and if so, by what mechanism? A case control study would be helpful in answering these questions. Ideally, a prospective follow-up of melanoma patients in a national registry would be established to determine differences in occurrence as well as outcome in women of differing hormonal status controlling for histological and other prognostic factors. Such investigations may provide insight into the patho-physiology or therapeutic management of a subset of patients with ocular melanoma.
